ALLIANCE A091401

Primary Category:

Treatment Protocols

Disease Category:

Sarcoma

Status:

Closed

Randomized Phase II Study of Nivolumab with or Without Ipilimumab in Patients with Metastatic or Unresectable Sarcoma

NCT#02500797

Effective Thursday, August 1, 2019, Alliance A091401 is permanently closed to new patient accrual.